SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - FIRST WAVE BIOPHARMA INC ownership

FIRST WAVE BIOPHARMA INC's ticker is and the CUSIP is 33749P101. A total of 21 filers reported holding FIRST WAVE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of FIRST WAVE BIOPHARMA INC
ValueSharesWeighting
Q1 2022$11,000
-35.3%
10,521
-8.4%
0.00%
Q4 2021$17,000
-74.2%
11,491
-51.1%
0.00%
-100.0%
Q3 2021$66,00023,5000.00%
Other shareholders
FIRST WAVE BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Kathleen S. Wright Associates Inc. 4,652$1,0000.00%
JANE STREET GROUP, LLC 45,239$9,0000.00%
US BANCORP \DE\ 5,102$1,0000.00%
BANK OF AMERICA CORP /DE/ 250$00.00%
FIRST MANHATTAN CO. LLC. 250$00.00%
WELLS FARGO & COMPANY/MN 5,698$1,0000.00%
NORTHERN TRUST CORP 11,889$2,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 91,026$18,0000.00%
STATE STREET CORP 41,838$8,0000.00%
View complete list of FIRST WAVE BIOPHARMA INC shareholders